A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Behavioral Disturbances in Patients With Dementia

A Study of the Safety and Effectiveness of Risperidone for the Treatment of Conduct Disorder and Other Disruptive Behavior Disorders in Children Ages 5 to 12 With Mild, Moderate, or Borderline Mental Retardation

NCT00250354 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Effectiveness and Safety of Risperidone Compared With Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder, and the Maintenance of Anti-manic Effectiveness of Risperidone Compared With Haloperidol

NCT00253162 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Effectiveness and Safety of Risperidone as add-on Therapy to Mood Stabilizers in the Treatment of Manic Episodes Associated With Bipolar Disorder

NCT00253149 ·Status: COMPLETED ·Phase: PHASE3

The Relationship Between Risperdal Treatment and Quality of Life in Patients With Alzheimer's Disease and Behavioural and Psychological Symptoms of Dementia (BPSD)

NCT00626613 ·Status: UNKNOWN ·Phase: PHASE4

A Study of the Safety and Effectiveness of Risperidone Versus Placebo for the Treatment of Conduct Disorder in Children With Mild, Moderate, or Borderline Mental Retardation

NCT00266552 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Effectiveness and Safety of Risperidone Versus Placebo as add-on Therapy to Mood Stabilizers, in the Treatment of Manic Episodes Associated With Bipolar Disorder.

NCT00250367 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Patients With Hallucinations and Delusions Associated With Alzheimer's Disease

NCT00287742 ·Status: TERMINATED ·Phase: PHASE3

Study Comparing Adjunctive Risperidone Versus Placebo in Major Depressive Disorder That Is Not Responding to Standard Therapy

NCT00095134 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder

NCT00249236 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder

NCT00257075 ·Status: COMPLETED ·Phase: PHASE3

Different Safety Profile of Risperidone and Paliperidone Extended-release

NCT01284959 ·Status: COMPLETED ·Phase: PHASE4

Antipsychotic Discontinuation in Alzheimer's Disease

NCT00417482 ·Status: COMPLETED ·Phase: PHASE4

Risperidone Augmentation in Patients With Schizophrenia

NCT00289861 ·Status: COMPLETED ·Phase: PHASE4

A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Children With Autistic Disorder and Other Pervasive Developmental Disorders (PDD)

NCT00261508 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Efficacy and Safety of Risperidone in the Prevention of Relapse in Children and Adolescents With Conduct and Other Disruptive Behavior Disorders

NCT00236444 ·Status: COMPLETED ·Phase: PHASE3

A Prospective Study of Risperdal (Risperidone) for the Treatment of Behavioral Disorder Following Psychological Therapy for Challenging Behavior in Learning Disabled Children

NCT00254930 ·Status: COMPLETED ·Phase: PHASE3

A Comparison of Risperidone With Haloperidol in Patients With Schizophrenia and Schizoaffective Disorder

NCT00253110 ·Status: COMPLETED ·Phase: PHASE4

Escitalopram Treatment for BPSD in Alzheimer's Disease in Comparison to Risperidone

NCT01119638 ·Status: COMPLETED ·Phase: PHASE4

A Study of the Effectiveness and Safety of Two Doses of Risperidone in the Treatment of Children and Adolescents With Autistic Disorder

NCT00576732 ·Status: COMPLETED ·Phase: PHASE4

Risperidone Treatment in Schizophrenia Patients Who Are Currently Taking Clozapine

NCT00056498 ·Status: COMPLETED ·Phase: PHASE4

Effect Of Talnetant Versus Risperidone Versus Placebo On Psychotic Symptoms In Schizophrenic Patients

NCT00300963 ·Status: COMPLETED ·Phase: PHASE2

A Study of Extended Release Extended-release (ER) OROS Paliperidone Tolerability, as Compared to Immediate-release (IR)Risperidone, in Patients With Schizophrenia

NCT00791232 ·Status: COMPLETED ·Phase: PHASE1

A Study of the Safety of Risperidone in the Treatment of Children and Adolescents With Conduct and Other Disruptive Behavior Disorders

NCT00236470 ·Status: COMPLETED ·Phase: PHASE3

A Comparison of Paliperidone and Risperidone for Treatment of Patirnts With Methamphetamine-Associated Psychosis

NCT01822730 ·Status: COMPLETED ·Phase: PHASE4

Study to Measure Drug Satisfaction of Patients With Schizophrenia After Switching From Risperidone to Paliperidone

NCT00535132 ·Status: COMPLETED ·Phase: PHASE4